SION (Sionna Therapeutics) Other Operating Expense: $0.06 Mil (TTM As of Mar. 2026)


SION Sionna Therapeutics Inc SION
12 GF Score
Price $44.91
! 3 Warning Signs
View Full Analysis

What is Sionna Therapeutics Other Operating Expense?

Sionna Therapeutics SION +4.20% 12 Other Operating Expense is $0.06 Mil as of Mar. 2026. GuruFocus rates SION with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

Sionna Therapeutics's Other Operating Expense for the three months ended in Mar. 2026 was $0.49 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $0.06 Mil.

Sionna Therapeutics's quarterly Other Operating Expense declined from Sep. 2025 ($0.52 Mil) to Dec. 2025 ($-1.43 Mil) but then increased from Dec. 2025 ($-1.43 Mil) to Mar. 2026 ($0.49 Mil).

Sionna Therapeutics Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Sionna Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sionna Therapeutics Other Operating Expense Chart

Sionna Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Operating Expense
0.00 0.00 0.00 0.00

Sionna Therapeutics Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.43 0.48 0.52 -1.43 0.49
SION
12GF Score
Sionna Therapeutics Inc SION
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sionna Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $0.06 Mil mean?
Sionna Therapeutics (SION) has a Other Operating Expense of $0.06 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Sionna Therapeutics and its competitors.
Is Sionna Therapeutics' Other Operating Expense too high?
Sionna Therapeutics' current Other Operating Expense is $0.06 Mil. Overall, Sionna Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Sionna Therapeutics' Other Operating Expense compare to TYRA and RAPP?
Sionna Therapeutics' Other Operating Expense of $0.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Sionna Therapeutics and its competitors. Sionna Therapeutics's current Other Operating Expense is $0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sionna Therapeutics stock overvalued right now?
Sionna Therapeutics (SION) has a current Other Operating Expense of $0.06 Mil. The current Other Operating Expense is $0.06 Mil. Sionna Therapeutics' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Sionna Therapeutics (SION), the current Other Operating Expense is $0.06 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sionna Therapeutics Business Description

Address 21 Hickory Drive, Suite 500, Waltham, MA, USA, 02451
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
12GF Score

Get the complete analysis for SION

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$44.91
Price